Calcium chloride is a blood coagulation factor indicated for the treatment of adult and pediatric patients with acute symptomatic hypocalcemia. It is available as injection for intravenous and intraventricular use. MedsAcross supplies Calcium chloride for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
From the regulator-approved product information. Each section names its source.
Calcium Chloride Injection is indicated for the treatment of adult and pediatric patients with acute symptomatic hypocalcemia. Limitations of Use The safety and effectiveness of Calcium Chloride Injection for long-term use has not been established. Calcium Chloride Injection is a form of calcium indicated for the treatment of adult and pediatric and patients with acute symptomatic hypocalcemia.
Source: US FDA prescribing information
Intravenous administration of calcium chloride increases serum ionized calcium concentration. Calcium chloride dissociates into ionized calcium in plasma.
Source: US FDA prescribing information
• Administer Calcium Chloride Injection by slow intravenous infusion (not to exceed 1 mL/minute), in a central or deep vein. • Do not use intramuscularly or subcutaneously. • Do not administer unless solution is clear and seal is intact. • Stop the administration if the patient complains of any administration-related discomfort, it may be resumed when symptoms disappear. • The recommended adult dose is from 200 mg to 1,000 mg. • The recommended pediatric dose is from 2.7 to 5 mg/kg of calcium chloride. • Repeated injections may be required because of rapid calcium excretion. • See the full prescribing information for the recommended starting dose in patients with renal impairment. • Do not mix Calcium Chloride Injection with ceftriaxone or administer these products simultaneously via a Y-site because concurrent use can lead to the formation of ceftriaxone-calcium precipitates.
Source: US FDA prescribing information
Calcium Chloride Injection is contraindicated in: • Patients with ventricular fibrillation • Patients with asystole and electromechanical dissociation Newborns (up to 28 days of age) if they require (or are expected to require) ceftriaxone intravenous treatment because of the risk of precipitation of ceftriaxone-calcium, regardless of whether these products would be received at different times or through separate intravenous lines. Calcium Chloride Injection is contraindicated in: • Patients with ventricular fibrillation. • Patients with asystole and electromechanical dissociation.
Source: US FDA prescribing information
• End-Organ Damage due to Intravascular Ceftriaxone-Calcium Precipitates: Calcium Chloride Injection is contraindicated in newborns (up to 28 days of age) if they require (or are expected to require) ceftriaxone intravenous treatment. In patients older than 28 days of age, do not mix or administer simultaneously with ceftriaxone intravenous solutions, even via different infusion lines or at different infusion sites as it can lead to precipitation of ceftriaxone-calcium. • Hypotension, Bradycardia, Arrhythmias, and Syncope with Rapid Administration: Too rapid an injection exceeding 1 mL/minute may lead to hypotension and syncope. • Arrhythmias with Concomitant Digoxin Use: Avoid use of Calcium Chloride Injection in patients receiving digoxin. Closely monitor ECG and calcium levels if concomitant therapy is necessary.
Source: US FDA prescribing information
The following serious adverse reactions are also described elsewhere in the labeling: • End-Organ Damage due to Intravascular Ceftriaxone-Calcium Precipitates • Hypotension, Bradycardia, Arrhythmias, and Syncope with Rapid Administration • Arrhythmias with Concomitant Digoxin Use • Tissue Necrosis and Calcinosis • Aluminum toxicity The following adverse reactions have been identified in literature and postmarketing reports of calcium chloride.
Source: US FDA prescribing information
• Digoxin: Avoid concomitant use with Calcium Chloride Injection. If concomitant use is unavoidable, monitor ECG closely during administration of Calcium Chloride Injection. • Calcium Channel Blockers: Avoid concomitant use with Calcium Chloride Injection. If concomitant use is unavoidable, monitor blood pressure closely during administration of Calcium Chloride Injection. • Drugs That Increase the Risk of Hypercalcemia: Increase the frequency of calcium concentration monitoring in patients taking Calcium Chloride Injection concomitantly with other drugs that increase the risk of hypercalcemia.
Source: US FDA prescribing information
Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C and 30°C (59°F and 86°F).
Source: US FDA prescribing information
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
2 presentations of Calcium chloride, sorted by availability.
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Calcium chloride 1000 mg/10 mL injectionIntravenousGeneric name | — | US FDA | Available on request |
| Calcium chloride 1000 mg/10 mL injectionIntravenous, intraventricularGeneric name | — | US FDA | Available on request |
Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.
| Register | Status | Source |
|---|---|---|
| US FDA | First approved 28 January 2000 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Conditions linked to Calcium chloride in public data. This is not a list of approved uses, see the clinical information.
Yes, on request. MedsAcross lists 2 presentations of Calcium chloride and sources them for licensed hospitals, importers and physicians against valid import documents.
Yes. The US FDA first approved Calcium chloride on 28 January 2000, according to Drugs@FDA.
No listed presentation of Calcium chloride is recorded as needing a cold chain. Storage conditions are shown on each presentation page.
Calcium chloride is classified under ATC code A12AA07 (Calcium chloride).
Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.